While the results suggest the existence of mechanisms regulating tau protein phosphorylation in physiological conditions, further study is required to clarify whether the currently identified mechanism could be extended to that for pathological phosphorylation that causes aggregate formation in neurodegenerative disorders, including Alzheimer’s disease and post-ischemic brain neurodegeneration [45]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.